The following is the first in an occasional series where we discuss current developments in the BioSTL ecosystem. In this first installment, we sat down with James McCarter, Managing Director of BioGenerator Ventures, the startup arm of BioSTL, to learn more about the organization’s new Hypha Life Sciences Venture Studio. Below is a summary of our wide-ranging conversation.
A Strategic Evolution Based on a Proven Track Record
The Hypha Life Sciences Venture Studio isn’t a net-new endeavor, rather it formalizes BioGenerator Venture’s previous successes with research tools and services companies it has created. What is new is the dedicated capital and the establishment of a formal studio focused on the tools and services space. BioGenerator is doubling down on founding, not just investing in and supporting, promising companies.
For example, Canopy Biosciences, now a part of Bruker Spatial Biology, was built and sold within five years; and Panome Bio, a multi-omics powerhouse reached millions in revenue and 25 employees in just three years. Both serve as a blueprint for the studio.
Hypha is built on BioGenerator’s 20-year foundation of providing the three essential ingredients for innovation and startup creation:
Funding: BioGenerator invests broadly across life sciences, including human health and agtech, spanning therapeutics, diagnostics, digital health, medical devices, research tools and services, and plant biology.
Talent: A core investment team of PhD scientists who conduct deep due diligence alongside entrepreneurs in residence (veteran leaders) and venture fellows (early-career talent).
Space: Two St. Louis-based dedicated biotech incubators with shared lab space.
A Lower-Risk, High-Impact Model
The studio focuses on research tools and services rather than higher-risk investments, such as therapeutics with longer timelines due to clinical trials and regulatory hurdles. While the latter provides a potential tenfold return over a decade, Hypha’s model prioritizes investments that tend to demonstrate revenue generation earlier and offer shorter windows to exit (on average 5 years). BioGenerator considers the venture studio model complementary to its other work and resonant in these uncertain times.
A “Sticky” Local Economy
Perhaps the most significant impact of Hypha is its contribution to the St. Louis economy.
Research tools and services companies tend to generate a lot of jobs in the early years. They are job engines. Because they offer a service or manufacture equipment and supplies, they require many skillsets from laboratory technicians to sales and marketing teams. These jobs tend to stay in the community. When Canopy Biosciences was acquired by Brucker Spatial Biology, a Boston-based company, Canopy’s 22 employees didn't leave. They stayed in St. Louis, strengthening the local ecosystem.
A Growing Portfolio Based on Opportunity and Gap Identification
As the name Hypha suggests, the studio is tethered to the “mother organism” while also exploratory. Hypha builds on BioGenerator’s previous successes in the research tools and services space, leveraging technologies in its portfolio. For example, Panome Bio, a BioGenerator portfolio company, pioneered a metabolomics technology for pharmaceutical research support. Hypha is now building on that technology with one of its first companies in the venture studio, Status Health, which brings environmental toxin exposure testing to everyday consumers.
The studio is also exploring gaps in the research tools and services space and determining how to fill them. BioGenerator has identified fertile ground in sourcing new ideas and technologies from outstanding, but "under-leveraged,” academic research institutions. These are typically institutions with great potential but fewer venture capital connections and startups.
With two new companies already incorporated, including Status Health, Hypha is doubling down on its formula for success: Funding, Talent, and Space. Or, as Jim said: “By providing all three, we aren't just betting on the future of life sciences; we are building it.”
The Path Forward: Prosperity that Works for St. Louis
BioSTL has been turning the promise of bioscience innovation into economic impact for St. Louis since 2001. The creation of an inclusive bioscience-driven economy is core to the organization’s work and supported by its workforce development program and BioGenerator’s fellows program. As Jim points out, it is important to understand that the companies in Hypha’s Venture Studio require people of all backgrounds and all levels of education. These companies create well paid, diverse job opportunities, which is key to the region’s prosperity.
Background Information:
BioGenerator Ventures, the Venture Studio Model and Hypha Name
Senior Managing Director, BioGenerator Ventures – the startup arm of BioSTL
2026 St. Louis Business 500: Leading Industries List
Innovators Hour: Panome Bio
The Venture Studio Model
A venture studio combines company building with venture funding to create, launch and grow startups. From ideation to launch and growth, the studio acts as a co-founder and provides capital, talent and operational support. The model is designed to compress time, allowing for faster, more iterative development focused on addressing a market need.
A venture studio is a way to build stronger teams and companies from the ground up.
Hypha Life Sciences Venture Studio
Hypha is led by a core team of PhD scientists and serial entrepreneurs, Hypha bridges the gap between academic research and market-ready research tools and services to drive scientific and economic progress.
The Hypha core team is highly experienced and has built and exited companies for decades:
David Smoller
Tom Cohen
Cory Berkland
Jim McCarter
The Origin of the Hypha Name
A hypha is a long, branching filamentous structure that serves as the main vegetative growth unit of a fungus, oomycete, or actinobacterium. Hyphae grow apically, which means from the tip, and branch out to explore their environment. Hyphae also serve to pass nutrients and signals between plants, supporting the growth and health of each.
The Hypha Life Science Venture Studio functions similarly, supporting the startups in its portfolio the way hyphae support the trees in a forest.